Given the multitude and diversity of pathways regulated by IQGAP3 in keratinocytes, targeting this protein for therapeutic inhibition may not be the most effective strategy to normalize the phenotype of keratinocytes is psoriasis. The gene discussed is IQGAP3; the disease is psoriasis.